People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.

An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.

What Are GLP-1 Patches? GLP-1 patches, mainly sold online, sometimes with catchy names like “Ozempatch,” promise to promote weight loss, suppress appetite, and boost energy levels.

As more research is done on GLP-1 drugs, the number of indications they can treat may grow significantly. And if tirzepatide is able to help treat cancer, it could make this already massive drug a ...

As a reporter, I've covered all things GLP-1. Here's what I've learned. From protein hacks to thinness myths, my reporting journey has been full of surprises.

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which categories are most at risk, where new opportunities lie, and how to innovate ...

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The hunger-reducing mechanisms of GLP-1 drugs, as well as their side ...

No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA vs DPP4i users.